An Obamacare Repeal Could Be A Win-Win For GOP On Drug Pricing

By John Wilkerson, Ariel Cohen / September 21, 2020 at 5:31 PM
If Obamacare were repealed, the president’s drug pricing executive orders would likely die with it, but the Supreme Court won’t rule on the Affordable Care Act until next year so President Donald Trump gets to bash big pharma during the campaign, then his signature drug pricing measures would be voided if a new, conservative-heavy high court scraps the entire health law, drug lobbyists said. Trump’s four drug pricing executive orders rely on demonstration authority created by the ACA, so they...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.